Methods. All eye-movement data were obtained using high-speed digital video, infrared reflection, or scleral search coil systems.
I
nfantile Nystagmus Syndrome (INS) I is an ocular motor sys tem dysfunction characterized by the rhythmic to-and-fro os cillations of the eyes, affecting about one in 3000 newborns.2•3 It may be inherited or spontaneous and either associated with a sensory deficit or not. INS is usually noted within the first few months of birth or at birth (especially in inherited cases) but can rarely develop later in life. Those INS patients with poor vision· usually have associated sensory deficits responsible for the greater part of their vision loss. However, the nystagmus. eye movements do affect visual function to a varying extent, especially when view ing lateral-gaze targets and fast-moving targets.
Approximately fifty percent ofINS patients also have impaired stereovision, an indication of strabismus, which is sometimes hid den by the nystagmus eye movements4; strabismus can easily be detected by accurate eye-movement recordings. Patients with INS generally donot perceive oscillopsia, however, under certain cir cumstances, oscillopsia can be elicited. The physical attributes of the stimulus, the experimental condition, and the role of individ ual attention may influence the perception of oscillopsia.5 •6 Because INS usually develops from infancy, the sensory visual and ocular motor systems both suffer from a low quality, unstable input because of the constantly moving retina. Successful treat ment of nystagmus in infants and children will significantly improve that input, thereby benefiting both systems in their devel opmental stages. The main goal of any nystagmus treatment should be to increase the foveation quality,?·8 e.g., lengthening foveation time, increasing foveation-period accuracy, and reducing foveation-period velocity. Reducing nystagmus intensity is a sec ondary, cosmetic goal. Successful treatment is not limited to in creased nulI-or primary-position visual acuity; nor should that be the sole focus of the treatment evaluation. In this review of the past 40 years ofINS research conducted in our Laboratory, we conclude that accurate eye-movement recordings should be used for diagno sis and both planning and evaluating nystagmus treatments. Be-cause we have always recorded eye movements, we were in a unique position to observe that clinical evaluations alone are often inaccu rate, inconsistent, and too insensitive to document therapeutic changes; this conclusion is shared by other researchers.9 This article will review multiple aspects of visual function that may be affected by nystagmus treatments and form a more complete evaluation paradigm for children and adults with INS.
Primary-Position Measured and Potential Visual Acuity
Many INS patients have a "null" point, which indicates higher visual acuity at a certain gaze angle? The null point is established during the developmental period of the visual system and usually does not change its nature over the years, i.e., a static gaze-angle null stays in the same position; a time varying null retains its (a) periodicity. The position of the null point may or may not be in primary gaze. Surgery or prisms can correct a lateral null to primary position, alleviating the need for a head turn. Evaluation of treat ment efficacy usually compares the null-or primary-position acu ity pre-and posttreatment. In the case of a corrected lateral null, the primary-position acuity would be vastly improved. Clinically, visual acuity is usually measured with a distance line-letter chart.
The direct results of peripheral nystagmus therapy [e.g., prisms, contact lenses, or extraocular muscle (EOM) surgery] are im proved INS waveforms. Measured visual acuity is only an indirect and idiosyncratic measure of INS waveform characteristics. [10] [11] [12] The improvement of measured acuity is dependent on a number of factors in addition to improvement of nystagmus; these factors include afferent visual deficits, patient age, associated strabismus, amblyopia, uncorrected refractive errors, and associated central nervous system disease. The quality of INS foveation periods is the single most important characteristic that directly affects visual function (not nystagmus amplitude nor frequency) . It is also the characteristic that is directly affected by therapies that alter EOM fimction. Therefure, an objective measure of the direct, eye-movement effects of nystagmus therapies related to target foveation quality was needed to assess INS and evaluate the results of therapy.
The Nystagmus Acuity Function (NAF) was developed to fill that void. It measures nystagmus foveation quality at various gaze angles. It is an objective measure of waveform foveation, and a predictor of potential visual acuity for INS patients with no affer ent deficits (see the next paragraph for INS with afferent deficits) . The NAF measures directly the treatment-induced waveform changes, specifically, the patient's ability to maintain fixation within a "foveation window" of ±0.5° (position) and ±4.00/s (velocity) . 13 It combines the following factors of nystagmus-waveform characteristics during target foveation: foveation time per cycle, the standard deviations of eye position, and the standard deviations of eye veloCity?,14,15 The NAF is defined by the following equation: The NAF is a function that is predicated on the assumption of an intact visual system and is linearly proportional to potential Snellen (de c imal) visual acuity; Fig. 1 shows this age-dependant linear relationship. The individual lines reflect the different maxi mum acuities of normal subjects for each age range.18,19 A subse quent version of the NAF, the eXpanded Nystagmus Acuity Function (NAFX) ,15,20 extended the position window to ±6.0° and the velocity window to ± 10.0° /s for patients incapable of controlling fixation well enough for good foveation (this is a common scenario in INS patients with afferent visual deficits) . The NAFX is defined by the following equation:
where the pooled estimator CT = �(S02 + SO'2)/2 SO' = pv p v) v (p/v)(SOJ, tris the foveation-period duration, T is calculated from the average T surface. 15 The NAF and the NAFX (both unitless numbers between 0 and 1.0, 1.0 being the best) h.tve been successfully used to evaluate the foveation quality of both INS and Fusion Malde velopment Nystagmus Syndrome (FMNS, formerly called la tent/manifest latent nystagmus) patients.10,12,13,21,22 Fig. 2 shows an example ofthe NAFX calculation performed by the interactive user interface created in our lab (software available at http://www .omlab.orglOMLAB_page/software/software.html). The calculation startswith choosing a steady, blink-free fixation section at the gaze angle of interest. Then, proper position and velocity windows for this section are set within the user interface. Detailed instructions are available online.2o The upper panel of Fig. 2 is the velocity trace of the chosen fixation section, the bold part of the waveform corresponding to the foveation periods detected by the velocity criteria of the NAFX algorithm. The middle panel of Fig. 2 is the position trace of the chosen fixation section; the bold part of the waveform corresponding to the foveation periods de tected by the position criteria of the NAFX algorithm. The lower panel of Fig. 2 is the final output of the NAFX, with the bold part of the waveform satisfYing both the position and velocity criteria; i.e., they are foveation periods and are the only data used to calcu late the NAFX. Thus, the amplitude of the INS waveform is not correlated with visual acuity. It is suggested that multiple measure ments be performed and averaged at each gaze angle.
A more recent use of the NAFX is to estimate the upper limits of visual acuity improvement that could be achieved with the reduc-. f 12 F non 0 nystagmus. or example, some INS patients already have a high primary-position NAFX with a corresponding potential acuity close to 20/20; however, their measured acuity might only be 20/100 because of a deficit in the afferent visual system that limits visual acuity improvement. Having obtained the primary position NAFX information of such a patient before hand, it is unlikely that treatment of the patient's nystagmus could raise the already-high NAFX values any higher, or increase the measured peak visual acuity. Therefore, such patients should not expect in creased acuity as a result of any treatment. There are, however, other aspects of visual function that can be improved (and, there fore, should be evaluated); they will be covered in the next sections. In addition, the reduction or elimination of torticollis provides its own functional benefits.
Combined with pretherapy measured acuity, the NAFX can also be used to predict the measured acuity improvement postfour-muscle tenotomy in patients with visual deficits.12 The ability to inform pa tients how much their nystagmus may improve is unique in the history 4 ,------,------,------,------,------,------,------, ,------,------,------ Nystagmus Acuity Function (NAFINAFX) challenging to obtain an adequate evaluation ofINS therapies.
To obtain eye-movement recordings for consistent comparison
of NAFX values, we suggest that a stress-free visual target (e.g.,
LED or laser spot) should be used, because distinguishing letters and shapes adds another level of stress, especially for patients of a younger age. In addition, the recording condition should be kept consistent pre-and posttreatment for valid evaluation.26
Breadth of the High-Acuity Field
The null breadth (better measured by the NAFX "peak") of INS individuals determines the high-acuity field they can utilize. We de fine the high-acuity field as the range of gaze angles where the acuity is Clinically, we agree that visual acuity should be measured at dif ferent lateral gaze angles before and after nystagmus treatments to better characterize their effectiveness. 27
Indeed, with a broader NAFX peak, INS individuals have a wider high-visual-function field in which they can perform tasks with sufficient accuracy. This results in better performance in ac curacy/speed critical events, which leads to the dynamic measure ment that we will introduce in the next section.
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.. Time (sec) system. If that hypothesis holds true, one would expect to find that the more broadening improvement, the more tatget acquisition improve ment. A future study, examining a latger population of patients, would be needed to quantifY this correlation.
Gaze-Maintenance Capability
Gaze maintenance is the ability to hold fixation on a target of interest. To the best of our knowledge, there is no systematic methodology ro measure the gaze-maintenance capability in INS individuals and how that capability is altered by effective nystag mus treatments. Recently, we examined an 8-year-old child with both INS and FMNS for postfour-muscle T&R evaluations. We did not find any change in her primary-position NAFX. Her pre surgical NAFX averaged 0.670 (corresponding to a potential acuity of 20/30) ; this high value precluded substantial NAFX improve ment.12 However, she exhibited striking differences in the gaze maintenance capability in the pre-and postsurgical examinations. Fig. 5 shows a comparison of her responses to a series of rightward and leftward step targets. The presurgical task performance was poor; she was struggling to arrive on the target and maintain her gaze. The postsurgical performance, however, showed maintained foveation of all the stepped tatgets. The postsurgical record also doc umented alternation of the fixating eye: in the first part of the record ing, she fixated with the right eye but switched to the left eye in the later patt. Although still exhibiting some fluctuation, she was on tatget most of the time. It is important to note that there was only a 6-month gap between the two examinations and, therefore, it was not an artention-level change that caused the gaze-maintenance improve ment. Poor gaze stability is common in children with INS but it was only the initially high NAFX that, by precluding an NAFX improve ment, made this a novel finding. Moreover, the patient's mother noted a significant improvement in her daily life behaviors, e.g., she now sits much farther away ftom the TV than before the T&R pro cedure. This is not an isolated anecdotal observation; it is representa tive of the immediate behavioral improvements noted in many other cases as well as those documented in the first canine subject to receive the four-muscle T&R procedure. 28 Establishing an objective measurement of INS gaze-maintenance capability in children is challenging because their eye-movement re cordings usually contain inartention, blinks, and head movements that can be easily misinterpreted by anyone without experience in INS-waveform evaluations, or by an automated algorithm. One pos sible methodology is to use the NAFX to distinguish those foveation periods within, and outside of, the patient's foveation window, and calculate the percentage of "on tatget" foveation time during a visual task.
DISCUSSION
We have introduced four important aspects of a more complete INS visual function assessment paradigm: (1) NAFX and visual acuity measurements in nullor primary position; (2) breadth of the NAFX peak and high-acuity field; (3) speed of target acquisition and (4) gaze�maintenance capability. To obtain the data for the above assessments, the eye-movement recording paradigm should include visual tasks in both primary position and lateral gaze, each target position lasting long enough (>5 s) for tatget acquisition to occur. A few repetitions of each task are recommended to ensure that enough data points can be collected for averaging or curve fitting.
Recording children with INS is inevitably more challenging than recording adults. In addition to the difficulty of paying atten tion to targets and following instructions, INS children might feel stressed to look at targets in a constrained (head fixed) condition and refuse to cooperate. In our lab, we perform uncalibrated, qual itative recording for infants that establishes a definitive diagnosis of the type of nystagmus present. Children aged from 2 to 5 are usually difficult to record; their eye-movement recordings, al though clinically valuable, may not be of the highest quality for publication purposes. From a cooperative child, we are able to diagnose the type of nystagmus and estimate the null points. The decision to have surgery is then made by the parents and surgeon, with the understanding that an early -surgery can bring more ben efits to the development of the visual system, and that possible surgery at a later point in life will be easier to plan. After the age of 5, it is usually possible to obtain high-quality, accurately calibrated ocular motor recordings. 26 Because of the necessity of eye-movement data for accurate di agnosis, estimation of possible therapeutic improvements, deter mination of the most effective therapy, and documentation of therapeutic improvements, eye-movement recordings should be come an integral part of nystagmus evaluation and treatment.
